The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment Including myocarditis and the new entity of non inflammatory left ventricular dysfunction-MedSci.cn

The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment Including myocarditis and the new entity of non inflammatory left ventricular dysfunction

Andres, MS; Ramalingam, S; Rosen, SD; Baksi, J; Khattar, R; Kirichenko, Y; Young, K; Yousaf, N; Okines, A; Huddart, R; Harrington, K; Furness, AJS; Turajlic, S; Pickering, L; Popat, S; Larkin, J; Lyon, AR

Andres, MS (通讯作者)，Guys & St Thomas NHS Fdn Trust, Cardiooncol Serv, Royal Brompton Hosp, Sydney St, London SW3 6NP, England.

Abstract

Background The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment Including myocarditis and the new entity of non inflammatory left ventricular dysfunction

科室

工具

服务